Stifel raises Badger Meter stock price target on growth outlook By Investing.com

Stifel lifted Badger Meter’s price target to $174 from $166 and kept a Buy rating, citing a transition to more normalized and sustainable growth after organic growth slowed to low-single digits. The stock is down 11% over the past year and trades at $161, below InvestingPro’s fair value estimate of $166, while the company’s latest quarter missed on EPS at $1.14 vs. $1.16 expected and revenue at $220.7 million vs. $231.98 million. Management also expanded its buyback authorization by $75 million to $150 million through November 30, 2028, but investors remain focused on the Puerto Rico PRASA project and second-half 2026 growth recovery.

Analysis

The immediate signal here is not just the company-specific rerating, but that the market is bifurcating between names with visible near-term growth acceleration and those where the next leg is dependent on execution around a single, potentially lumpy project. That makes the stock vulnerable to a narrative reset if investors conclude the current slowdown is not just normalization but a more durable demand deceleration. In that regime, buybacks help on the downside, but they rarely re-rate a stock when the core growth algorithm is under scrutiny.

The key second-order issue is timing mismatch: the market wants proof over the next 1-2 quarters, while the apparent growth inflection is being pushed into late 2026. That creates a long air pocket where expectations can drift lower, especially if channel checks on the Puerto Rico project suggest slippage. If guidance comes in merely “stable” rather than reaccelerating, the stock can underperform even on clean execution because the market is likely positioned for a second-half recovery story.

For Amazon, the listed move is more about optionality than immediate P&L, but it reinforces the strategic premium on cash-rich acquirers using balance sheet capacity to secure scarce assets. For suppliers and adjacent industrial tech names, this can widen valuation dispersion: high-quality recurring revenue businesses with secular adoption cycles should keep a premium, while names tied to cyclical or policy-driven demand may stay trapped despite capital returns. The contrarian takeaway is that this is likely less a “cheap valuation” setup than a catalyst-deficit setup unless management can show the growth trough is already behind them.

Key Decisions for Investors

• Short BMI into earnings / guidance: use the next 1-3 weeks as a tactical fade if the stock remains above pre-release levels; target downside of 8-12% if management only reiterates a muted outlook, with buybacks providing limited support.
• Buy BMI put spreads dated after April 17 or into the next earnings cycle: structure for a controlled premium outlay to express risk that the Puerto Rico recovery gets pushed out, with asymmetric payoff if the market starts discounting 2H26 more aggressively.
• Pair trade: long AMZN / short BMI for 1-3 months if the theme is strategic capital deployment versus slow-growth industrial exposure; this isolates balance-sheet optionality against guidance risk.
• If long BMI for quality/dividend reasons, hedge with a 3-6 month collar: keep upside to the analyst target while protecting against a 10% drawdown if the company fails to validate the growth reacceleration thesis.